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To the Editor:  40 
Since the end of February 2020, when the first cases of coronavirus disease 2019 (COVID-19) due to 41 
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were identified in Italy, the 42 
metropolitan area of Milan has been greatly affected by the spread of the disease. Individual case 43 
reports1 and studies of case series2-5 have recently highlighted the presence of chilblain-like acral 44 
manifestations in young COVID-19 patients.  45 
Between 26 March and 26 April 2020, 30 patients with a median age of 11 years (range, 2-17) and 46 
chilblain-like acral lesions who had not started treatment with any new drug in the 15 days preceding 47 
lesion onset were referred to the Pediatric Dermatology Unit of the University of Milan (Table 1). 48 
Seventeen (56.7%) were male. 49 
Thirteen patients (43.3%) experienced systemic symptoms a median of six days (range, -1 to 35 days) 50 
before skin lesion onset, the most frequent being fever (n=9/13; 69.2%), followed by cough (n=6/13; 51 
46.2%), coryza (n=3/13; 23.1%), pharyngodynia (n=2/13; 15.4%), weakness (n=2/13; 15.4%), dyspnea 52 
(n=2/13; 15.4%), abdominal pain (n=1/13; 7.7%), and headache (n=1/13; 7.7%). 53 
In all cases, the lesions were erythematous-violaceous patches or slightly infiltrated plaques, 54 
associated with edema in three cases (Fig.1A-D). No blisters, crusts or ulcers were observed. Twenty-55 
six patients (86.7%) had foot lesions, two only involving the ankle, and four patients had hand 56 
lesions, including two with foot involvement. Lesion distribution was unilateral in four cases (13.3%). 57 
Usually moderate itching (median visual analogue scale [VAS] score = 4.5) was recorded in 14 58 
patients (46.7%), and pain in five (16.7%; median VAS score = 3). The median duration of the lesions 59 
in the nine patients whose lesions healed was seven days (range, 1–23). Two patients underwent a 60 
skin biopsy, and histology showed perivascular and periadnexal dermal lymphocytic infiltrates 61 
suggesting chilblains. (Fig.1E) Polymerase chain reaction (PCR)-based testing of nasopharyngeal 62 
swabs for SARS-CoV-2 was negative in all six patients tested.  63 
Like other centres,2,5 our Pediatric Dermatology Unit, which has a catchment area of about 3,000,000 64 
people, has recently been occupied by an “outbreak” of 30 cases of chilblain-like lesions, in 65 
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comparison with only three cases of authentic chilblains in the corresponding period of 2019. The 66 
lesions are probably vasculopathic and, although their etiopathogenesis is still unclear, it seems to be 67 
related to SARS-CoV-2 infection. Interestingly, median latency time in our cohort was shorter than 68 
that reported in previous series,2,4 and was slightly longer in the patients aged < 10 years (7.5 vs 6 69 
days). This manifestation usually appears in asymptomatic or paucisymptomatic children, who do not 70 
often undergo SARS-CoV-2 testing in Italy for economic reasons. The recognition of chilblain-like 71 
lesions may facilitate a diagnosis of COVID-19 in asymptomatic/paucisymptomatic pediatric patients.   72 
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TABLE 1. Demographic and clinical data of patients with chilblain-like lesions observed at the Pediatric Dermatology Unit of the University of Milan between 100 
26 March 26 and 26 April 2020 101 
ID Gender 
Age at 
diagnosis 
Residence 
Nasopharyngeal 
swab for SARS-
CoV-2 
Cohabitants with systemic 
symptoms/COVID-19 in the four 
weeks preceding lesion onset 
Systemic 
symptoms 
Time between 
systemic 
symptoms and 
onset of lesions 
(days) 
Duration of 
lesions 
(days) 
Location of 
lesions 
Distribution 
of lesions 
Itching 
(visual 
analogue 
scale) 
Local pain 
(visual 
analogue 
scale) 
1 F 10 
Milan 
(province) 
No // None Not applicable 23 Feet (toes) Bilateral 0 0 
2 F 17 Milan (city) Negative 
Grandfather died of COVID-19 
pneumonia 
Fever 13 
12 
(ongoing) 
Hand 
(fingers) Unilateral 2 0 
3 F 4 Milan (city) No // Fever -1 3 
Feet (toes, 
dorsum) Bilateral 0 0 
4 M 12 
Milan 
(province) 
No // None Not applicable 9 (ongoing) 
Feet (toes, 
soles) Bilateral 5 0 
5 F 11 
Milan 
(province) 
No 
Both parents (fever); not tested  
for SARS-CoV-2 
Fever, coryza, 
cough, abdominal 
pain 
1 
16 
(ongoing) 
Feet (toes) 
Bilateral 2 0 
6 F 17 
Milan 
(province) 
No 
Two friends affected by COVID-
19 (fever, cough) 
None Not applicable 
18 
(ongoing) 
Feet (soles) 
Bilateral 5 0 
7 M 6 
Milan 
(province) 
No // None Not applicable 
10 
(ongoing) 
Hands 
(palms), 
feet (soles) 
Bilateral 6 0 
8 M 17 
Milan 
(province) 
No // None Not applicable 
25 
(ongoing) 
Feet (toes) 
Bilateral 0 3 
9 M 16 
Milan 
(province) 
No // None Not applicable 
24 
(ongoing) 
Feet (toes) 
Bilateral 0 4 
10* F 11 
Milan 
(province) 
Negative 
Mother (cough); tested negative 
for COVID-19  
Fever, headache 1 
32 
(ongoing) 
Feet (soles, 
dorsum) Bilateral 1 0 
11 F 11 
Milan 
(province) 
No // Cough, dyspnea 30 
18 
(ongoing) 
Feet (toes) 
Bilateral 0 0 
12 M 17 
Milan 
(province) 
No // None Not applicable 
24 
(ongoing) 
Feet 
(dorsum) Bilateral 0 2 
13 M 11 Milan (city) No // None Not applicable 
39 
(ongoing) 
Foot (toes) 
Unilateral 0 0 
14 F 13 
Milan 
(province) 
No 
Father (fever, cough); not tested  
for SARS-CoV-2 
None Not applicable 
13 
(ongoing) 
Feet (toes) 
Bilateral 0 0 
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15 M 10 
Milan 
(province) 
No  None Not applicable 
21 
(ongoing) 
Foot (toe) 
unilateral 0 0 
16 M 14 
Milan 
(province) 
No // coryza, weakness 2 
17 
(ongoing) 
Foot (sole) 
unilateral 0 0 
17 M 11 
Milan 
(province) 
No // None Not applicable 1 
Ankles 
Bilateral 0 0 
18 M 2 
Milan 
(province) 
No 
Mother (cough and coryza); not 
tested for SARS-CoV-2 
cough, coryza 5 5 
Hands 
(palms) Bilateral 0 0 
19 M 4 
Milan 
(province) 
No // None Not applicable 7 
Feet (soles) 
Bilateral 0 0 
20* F 11 Milan (city) Negative 
Both parents (cough); father 
tested negative for SARS-CoV-2 
fever, cough 6 19 
Feet (toes, 
dorsum) Bilateral 2 0 
21* F 6 
Milan 
(province) 
Negative 
Mother (fever); tested negative 
for SARS-CoV-2 
fever 10 7 
Feet (toes, 
soles) Bilateral 0 3 
22* M 5 Milan (city) Negative 
Grandfather with bilateral 
pneumonia (not tested for SARS-
CoV-2); mother tested negative 
for SARS-CoV-2 
cough, dyspnea 35 24 
Feet (toes, 
soles), hand 
(palm) 
Bilateral 1 5 
23 F 6 Milan (city) No // None Not applicable 
14 
(ongoing) 
Feet (toes, 
soles) Bilateral 0 0 
24 M 14 Milan (city) Negative // None Not applicable 
19 
(ongoing) 
Feet (toes) 
Bilateral 5 0 
25 M 4 
Milan 
(province) 
No 
Mother with COVID-19 
(presenting with fever and 
cough) 
Fever, 
Pharyngodynia 
2 8 (ongoing) 
Ankles 
Bilateral 3 0 
26 M 14 
Milan 
(province) 
No 
Father (fever, cough, dyspnea); 
not tested  for SARS-CoV-2 
None Not applicable 
24 
(ongoing) 
Feet (toes) 
Bilateral 0 0 
27 M 13 
Milan 
(province) 
No // None Not applicable 6 (ongoing) 
Feet (toes, 
soles) Bilateral 4 0 
28 M 16 
Milan 
(province) 
No 
Sister (fever); not tested for 
SARS-CoV-2 
fever 21 9 (ongoing) 
Feet (toes) 
Bilateral 5 0 
29 F 10 
Milan 
(province) 
No // 
Fever, cough, 
weakness, 
pharyngodynia  
30 
20 
(ongoing) 
Feet (toes) 
Bilateral 5 0 
30 F 14 
Milan 
(province)  
No 
Sister (fever, cough, 
pharyngodynia, weakness)  
None Not applicable 3 
Feet (toes) 
Bilateral 5 0 
SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; *described in a previous paper published by some of us (CC, NAM, FB and RG) (Colonna C et al. Pediatr Dermatol. 2020 May 6. 102 
doi: 10.1111/pde.14210. [Epub ahead of print]) 103 
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FIGURE LEGENDS 104 
Figure 1. Chilblain-like acral lesions in four patients. A, Erythematous-violaceous non-infiltrated patches on the toes of a 10-year-old girl (patient 1). B, 105 
Violaceous non-infiltrated patches on the toes of a 16-year-old boy (patient 28). C, Violaceous slightly infiltrated plaques on the fingers of a 17-year-old girl 106 
(patient 2). D, Violaceous lesions on the heel of a 11-year-old girl (patient 11); E, Case 10. Histology revealed dense perivascular cuffs of lymphocytes and 107 
periadnexal lymphocytic infiltrates in the dermis. Hematoxylin and eosin stain; original magnification x20 108 

